Immunoendocrine regulation of energy homeostasis and male reproduction

Male reproduction and its intricate neuroimmunoendocrine regulations open a wide scope of scientific interventions. Male infertility, being responsible for about half of the overall global infertility cases, represents a complex pathophysiological mechanism. Crosstalk among the endogenous immune and endocrine mediators may affect male gonadal functions. Since male reproduction is fine-tuned by orchestrated regulation of reproductive hormones and immune regulators, a better understanding of these chemical regulations will potentiate further research in this direction.

This issue aims to summarize the current knowledge on the hormonal and immunological regulations of male reproductive functions in physiological and pathophysiological conditions of male reproduction.

Potential topics include but are not limited to the following:

  • Energy homeostasis  and male reproduction
  • Immunoendocrine regulation of male reproductive functions
  • Adipokines and energy metabolism in male fertility
  • Obesity and male infertility: energy imbalance to inflammation
  • Endocrine regulation of epigenetics of reproductive tract inflammation
  • Altered energy metabolism and immune regulation in aged men
Submission Deadline 30th June 2021
Publication Date 1st Sept 2021

Guest Editors:

Pallav Sengupta, PhD
Department of Physiology
Faculty of Medicine & Biomedical Sciences
MAHSA University
Sulagna Dutta, PhD
Department of Physiology
Faculty of Dentistry
MAHSA University


Article (Research articles and Review Articles) should be submitted online on the journal site as per author guidelines. Authors need to indicate submission to special issue in cover letter to editor.

There is no publication charges for publishing in special issue or in Chemical Biology Letters.

Nanobiotechnology and Biomaterials in Nuclear Medicine – special issue

Nuclear Medicine, a medical specialty involving the application of radioactive substances and magnetic materials in the diagnosis and treatment of disease have been highly successful in diagnosis of difficult to detect diseases and therapy of various dreaded diseases. Recently, there have been a tremendous research progress in development of newer methods, conjugates and pharmaceuticals for diagnosis and therapy using nanomaterials and nanomedicine approaches in radioactive materials.

The purpose of this special issue proposal is to summarize the recent advances in the field of new NanoMedicinal and Nanobiotechnological advances in development of probes and materials for potential molecular targets and understanding of their mechanism of actions, new radioconjugates development using nanobiomaterials, clinical evaluation and application of new Nano-radiopharmaceuticals, and new techniques/therapy development using Biomaterials. Recent progress will be covered through research articles, review articles and short communications.

The subtopics to be covered in this issue are (though not limited to):

NanoChemistry of new radioactive elements.
– Organic chemistry of Nano-radiopharmaceuticals, chelating agents and standalone Nano-radiopharmaceuticals.
– Progress in SPECT using Nanobiomaterials.
– Progress in Nano-Positron Emission Tomography (nanoPET).
– Application of nanoscience and nanotechnology to Nuclear Medicine.
– Identification of new therapeutic targets.
– Treatment advances of various diseases – cancer, infections, inflammations etc using nano-radiopharmaceuticals.
– Clinical studies and evaluation of nano-radiopharmaceuticals.
– Malarial/mycobacterial/microbial/viral diagnosis and therapy development using nano(bio)materials including biochemical aspects of nano-biomaterials.
– Therapeutic and diagnostic applications of new nano and biomaterials.
– New therapeutic policies and emerging targets for Nuclear nanoMedicine.
– New approaches adopted for the development of nanomedicine of new radiodiagnostic and radiotherapeutic molecules.
– Rational design and drug discovery-Structure-activity relationship (SAR).
NanoDrug Delivery of radiopharmaceuticals – application of different nanobiotechnology conjugates and systems in radiopharmaceuticals.
– Synthetic strategies of new radioactive conjugate molecules.
– Molecular self-assembly as drug delivery carriers of radiopharmaceuticals – Nanotechnology and Biotechnology.
– Environmental aspects, safety measures advances in nuclear medicine.

Provisional Schedule:

Manuscript submission: Submission open and ongoing now.
Issue Completion: August 2020.


Dr. Anil Mishra
Dr. Anil Kumar Mishra
Scientist ‘G’ and Add Director,
Institute of Nuclear Medicine and Allied Science,
DRDO, Timarpur, Delhi. India
Dr. B.S. Chhikara,
University of Delhi
email: drbs @ aditi.

Nuclear and Nano-Medicine researchers are invited to submit their research / review article for this special issue. Manuscript should be prepared and submitted as per author guidelines provided on journal site.

Important Links:

Author Guidelines for preparation of manuscript:

Manuscript template (download): Download template MS word 2007-2010, Citation manager style files and other details are provided in author guidelines section on journal site. section -nanomaterials-materials-nanoscience/

Manuscript Submission: Authors need to submit their manuscript on OR (India-regional site).

There is no fees for publication in special issue or journal.